belkyra deoxycholic acid 10 mg/ml injection glass vial
abbvie pty ltd - deoxycholic acid, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections; dibasic sodium phosphate heptahydrate; hydrochloric acid - belkyra (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults
ursodeoxycholic acid lapl ursodeoxycholic acid 250 mg capsules blister pack
generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate - ursodeoxycholic acid lapl (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.
ursodeoxycholic acid lupin ursodeoxycholic acid 250 mg capsules blister pack
generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: magnesium stearate; maize starch; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate - ursodeoxycholic acid lupin (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.
apo-ursodeoxycholic acid ursodeoxycholic acid 250 mg capsule blister pack
arrotex pharmaceuticals pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule - excipient ingredients: titanium dioxide; maize starch; silicon dioxide; gelatin; magnesium stearate - ursodeoxycholic acid is indicated in the treatment of chronic cholestatic liver diseases.
ursodeoxycholic acid apotex ursodeoxycholic acid 250 mg capsule blister pack
gm pharma international pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule - excipient ingredients: silicon dioxide; gelatin; titanium dioxide; maize starch; magnesium stearate - ursodeoxycholic acid is indicated in the treatment of chronic cholestatic liver diseases.
ursodox gh ursodeoxycholic acid 250 mg capsules blister pack
generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: magnesium stearate; colloidal anhydrous silica; maize starch; titanium dioxide; iron oxide yellow; gelatin - ursodox gh (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.
urso ursodeoxycholic acid 250mg/5ml oral liquid bottle
dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 50 mg/ml - oral liquid, suspension - excipient ingredients: benzoic acid; glycerol; citric acid; sodium chloride; purified water; sodium citrate dihydrate; propylene glycol; xylitol; sodium cyclamate; microcrystalline cellulose; carmellose sodium; flavour - treatment of chronic cholestatic liver diseases.
urso ursodeoxycholic acid 500 mg tablet blister pack
dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; polysorbate 80; crospovidone; purified talc; macrogol 6000; magnesium stearate; povidone; colloidal anhydrous silica; hypromellose - the treatment of chronic cholestatic liver diseases
ursofalk ursodeoxycholic acid 500 mg tablet blister pack
dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: povidone; purified talc; polysorbate 80; hypromellose; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; crospovidone; macrogol 6000 - treatment of chronic cholestatic liver diseases
ursodox lupin ursodeoxycholic acid 250 mg capsules blister pack
generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate - ursodox lupin (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.